NFE2L2 and neoplasm: Another family of NRF2 effectors are the aldo-keto reductases (AKRs, AKR1B, AKR1C1/2 and AKR1C3) which are upregulated in many LUSC and some LUAD tumor biopsies with somatic mutations in the NFE2L2 gene [120].